Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Stuttgart - Delayed Quote EUR

Grifols SA (OZTA.SG)

Compare

10.43

+0.03

+(0.29%)

At close: February 28 at 12:11:27 PM GMT+1

Is Grifols, S.A. (GRFS) the Best Low Price Pharma Stock to Invest In Right Now?

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Grifols, S.A. (NASDAQ:GRFS) stands against the other pharma stocks. The Rising Demand for Weight-Loss Medications and GLP-1 Developments Healthcare, which includes numerous businesses that offer patient […]

Insider Monkey 2 days ago

GRFS
Grifols SA (GIFLF) (Q4 2024) Earnings Call Highlights: Record Revenues and Strategic ...

Grifols SA (GIFLF) reports robust growth in its biopharma segment and significant balance sheet improvements, despite facing currency and margin pressures.

GuruFocus.com 2 days ago

GRFS
Exploring High Growth Tech Stocks In February 2025

As global markets navigate a volatile start to 2025, with the Federal Reserve holding rates steady and AI competition shaking up the tech sector, investors are closely watching how these dynamics impact high-growth opportunities. In this climate of rapid technological advancements and shifting economic indicators, identifying promising tech stocks involves assessing their innovation potential and resilience in adapting to emerging challenges like those posed by new AI developments.

Simply Wall St. 22 days ago

GIFLF

GIFOF

GIKLY
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease

‘Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms appear, leading to new diagnostic tools and disease-modifying therapiesPart of broad Grifols program to find disease-revealing clues in more than 100 million proprietary plasma samples connected to real-world data on thousands of disease states in many therapeutic areasCutting-edge use of AI and proteomics technology paired with real-world evidence unde

GlobeNewswire last month

GIFLF

GIFOF

GIKLY
Mason Capital complains about Grifols' transparency to Spanish regulator

U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical company Grifols. The activist fund said in a statement it had identified potential conflicts of interest linked to related party transactions by current board members, failure of internal controls and a "rumoured clause" in a recent bond issuance that benefits Canadian fund Brookfield at shareholders' expense. "We urge the CNMV to consider the benefits to all Grifols shareholders from improved disclosure," Mason Capital said.

Reuters last month

GRFS
Exploring Three High Growth Tech Stocks For Future Potential

As global markets navigate a mixed economic landscape marked by declining consumer confidence and fluctuating indices, technology stocks continue to capture attention with their potential for high growth. In this environment, identifying promising tech stocks involves assessing factors such as innovation, market demand, and the ability to adapt to changing economic conditions.

Simply Wall St. last month

GIFLF

GIFOF

GIKLY
Exploring High Growth Tech Stocks This December 2024

As global markets reach new heights, with indices like the Russell 2000 hitting record intraday highs, investor sentiment remains buoyed by domestic policy developments and easing geopolitical tensions. In this environment, identifying high-growth tech stocks that can capitalize on current economic trends and technological advancements is crucial for investors seeking to navigate the evolving landscape of December 2024.

Simply Wall St. 2 months ago

GIFLF

GIFOF

GIKLY
Sector Update: Health Care Stocks Slipping Late Afternoon

Health care stocks were easing late Monday afternoon, with the NYSE Health Care Index and the Health

PREMIUM
MT Newswires 2 months ago

PTCT

SNTI

NVS
Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?

On Wednesday, Grifols SA (NASDAQ:GRFS) said it ended discussions with Brookfield Capital Partners (UK) Limited about a potential acquisition. This decision follows the company’s November 19 statement rejecting Brookfield’s indicative offer to acquire Grifols for 6.45 billion euros ($6.81 billion) or 10.50 euros per Class A share. Canadian fund Brookfield said it had dropped its plan to take over Spain’s Grifols due to a disagreement over the pharmaceutical company’s value, while Grifols said it

Benzinga 2 months ago

GRFS
Grifols Stock Declines After Brookfield Drops Buyout Offer

Brookfield decides to drop its buyout offer for GRFS following discrepancies over the company's valuation.

Zacks 3 months ago

GRFS

BAM

SPRO
Sector Update: Health Care Stocks Rise in Late Afternoon Trading

Health care stocks were higher late Wednesday afternoon, with the NYSE Health Care Index and the Hea

PREMIUM
MT Newswires 3 months ago

GRFS

BAM
Top Midday Decliners

Symbotic (SYM) said it submitted a notification of late filing for its annual report for the fiscal

PREMIUM
MT Newswires 3 months ago

GRFS

SYM
Update: Market Chatter: Grifols' Family Won't Welcome Other Takeover Bids as Brookfield Walks Away

(Updates with Brookfield statement in the second paragraph.) Grifols (GRFS) has decided not to we

PREMIUM
MT Newswires 3 months ago

GRFS

BAM
Sector Update: Health Care Stocks Rise Pre-Bell Wednesday

Health care stocks rose premarket Wednesday as the Health Care Select Sector SPDR Fund (XLV) advance

PREMIUM
MT Newswires 3 months ago

GRFS

OTLK
Market Chatter: Brookfield Set to Drop Grifols Bid as Family Shuns Others

Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over di

PREMIUM
MT Newswires 3 months ago

GRFS

BAM
Market Chatter: Grifols' Family Won't Welcome Other Takeover Bids as Brookfield Walks Away

Grifols (GRFS) has decided not to welcome a new takeover bid by a third-party as Brookfield Asset Ma

PREMIUM
MT Newswires 3 months ago

GRFS

BAM
Grifols shares tumble after Brookfield drops takeover plan

MADRID (Reuters) -Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over the pharmaceutical company's value, while Grifols said it concurred with the decision. Brookfield had filed a non-binding offer on Nov. 19 for Grifols that valued the developer of human plasma-based drugs at 6.45 billion euros ($6.79 billion), which Grifols then said was a significantly undervalued offer and told its shareholders to stick to their shares. Grifols shares closed 9.07% down on Wednesday after falling more than 12% in earlier trading after Bloomberg first reported Brookfield's decision.

Reuters 3 months ago

GRFS
Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

Per GRFS, Brookfield's offer to buy its entire outstanding share capital for 6.45 billion euros significantly undervalues GRFS' prospects and long-term potential.

Zacks 3 months ago

GRFS

BAM

CTMX
GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment

The potency of GIGA-2339 is claimed to be more than 2,000 times greater than that of plasma-derived HBV treatments.

Clinical Trials Arena 3 months ago

GRFS
Grifols: Brookfield's potential $6.8 billion offer undervalues the firm

MADRID (Reuters) -Grifols said on Tuesday that Canadian investment fund Brookfield's potential 6.45 billion euro ($6.8 billion) offer significantly undervalued the Spanish drugmaker's prospects and long-term potential, telling shareholders to stick to their shares. Earlier on Tuesday, Brookfield said it was considering a public offer for Grifols at 10.50 euros per A share and 7.62 euros per B share, implying a company valuation of 6.45 billion euros. The proposal is non-binding, Brookfield said in a filing to the Spanish stock market regulator.

Reuters 3 months ago

GRFS

Performance Overview

Return	OZTA.SG	IBEX 35...
YTD	+15.32%	+15.69%
1-Year	-9.70%	+31.97%
3-Year	-31.17%	+57.28%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Grifols SA (OZTA.SG)

Is Grifols, S.A. (GRFS) the Best Low Price Pharma Stock to Invest In Right Now?

Grifols SA (GIFLF) (Q4 2024) Earnings Call Highlights: Record Revenues and Strategic ...

Exploring High Growth Tech Stocks In February 2025

Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease

Mason Capital complains about Grifols' transparency to Spanish regulator

Exploring Three High Growth Tech Stocks For Future Potential

Exploring High Growth Tech Stocks This December 2024

Sector Update: Health Care Stocks Slipping Late Afternoon

Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?

Grifols Stock Declines After Brookfield Drops Buyout Offer

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

Top Midday Decliners

Update: Market Chatter: Grifols' Family Won't Welcome Other Takeover Bids as Brookfield Walks Away

Sector Update: Health Care Stocks Rise Pre-Bell Wednesday

Market Chatter: Brookfield Set to Drop Grifols Bid as Family Shuns Others

Market Chatter: Grifols' Family Won't Welcome Other Takeover Bids as Brookfield Walks Away

Grifols shares tumble after Brookfield drops takeover plan

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment

Grifols: Brookfield's potential $6.8 billion offer undervalues the firm

Performance Overview